. Adult male Sprague-Dawley rats weighing 300-350 g were anesthetized with pentobarbital Na (30 mg/kg, ip). The heart was quickly isolated and the aorta was cannulated for retrograde Langendorff perfusion. N-2-hydroxy-ethylpiperazine-N'-2-ethanesulfonic acid (HEPES)-buffered Tyrode solution (140 mmol/L NaCl, 6 mmol/L KCl, 1 mmol/L MgCl2, 2 mmol/L CaCl2, 10 mmol/L HEPES, 10 mmol/L J 2002; 66: 390 -396 (Received September 28, 2001; revised manuscript received January 9, 2002; accepted January 11, 2002 ]i dynamics and left ventricular pressure were monitored in perfused beating hearts. The effects of KB-R7943 (KBR), a selective inhibitor of the NCX in the reverse mode, were analyzed during low-Na + exposure and ischemia -reperfusion. Hearts from Sprague-Dawley rats were retrogradely perfused and loaded with 4 mol/L fura-2 to measure the fluorescence ratio as an index of [Ca 2+ ]i. To evaluate KBR effects on the reverse mode exchanger, the increase in [Ca 2+ ]i induced by low-Na + exposure (Na + : 30 mmol/L, 10 mmol/L caffeine pre-treatment) was measured with and without 10 mol/L KBR (n=5). In another series, the hearts were subjected to 10 min of low-flow ischemia with pacing, followed by reperfusion in the absence (n=6) or in the presence of 10 mol/L KBR (n=6). Background autofluorescence was subtracted to estimate the ratio in the ischemia -reperfusion protocol. KBR significantly suppressed the increase in [Ca 2+ ]i induced by low-Na + (40.2±11.2% of control condition, p=0.014), as well as on increase in diastolic [Ca 2+ ]i during ischemia (% increase from pre-ischemia in [Ca 2+ ]i at 10 min: KBR, 17.9±6.4%; no KBR, 44.4±7.7%; p=0.024). After reperfusion, diastolic [Ca 2+ ]i normalized more rapidly in KBR-treated hearts (% increase at 1 min: KBR, 4.5±7.0%; no KBR, 39.8±12.2%; p=0.03). Treatment with KBR also accelerated recovery of the rate -pressure product on reperfusion (1 min: KBR, 8,944±1,554 min -1 ·mmHg; no KBR, 4,970±1,325; p<0.05). Thus, inhibition of the reverse mode exchanger by KBR reduced ischemic Ca 2+ overload and possibly improved functional myocardial recovery during reperfusion in a whole heart model. (Circ J 2002; 66: 390 -396) 
actors that affect the process of myocardial injury induced by ischemia -reperfusion include free radicals, 1 oxygen tension 2 and the ATP-sensitive K + channel. 3 Intracellular Ca 2+ overload also leads to myocardial injury in ischemia -reperfusion [4] [5] [6] [7] [8] and the sarcolemmal Na + /Ca 2+ exchanger (NCX) is thought to be a major factor in the excessive Ca 2+ influx. 4, [6] [7] [8] [9] Some previous reports have suggested that inhibition of the reverse mode of the NCX could protect ischemic myocardial cells against Ca 2+ overload, [7] [8] [9] but exchanger-related alterations in cytoplasmic Ca 2+ ([Ca 2+ ]i) and the effects of pharmacological intervention at the level of the NCX have not been fully described. KB-R7943 (2-[2-[4-(4-nitrobenzyloxy)phenyl] ethyl]isothiourea methanesulfonate; KBR) selectively inhibits the reverse mode of the NCX in isolated cells, 10, 11 and has been shown to reduce anoxia-induced accumulation of [Ca 2+ ]i and prevent reoxygenation-induced hypercontracture in isolated rat cardiomyocytes. 7 A demonstration of an alteration of [Ca 2+ ]i in pathologic models of the whole heart remains elusive; measurements of [Ca 2+ ]i have been carried out mainly in single-cell models and the factors involved in the ischemic whole heart are more complex than in anoxic or hypoxic myocytes. Langendorff's perfused heart loaded with [Ca 2+ ]i indicators has been used, [12] [13] [14] [15] [16] [17] [18] but the influence of NCX inhibition on [Ca 2+ ]i overload induced by ischemia -reperfusion was not addressed in those studies. The present study was designed to test the inhibitory effect of KBR on the increase in [Ca 2+ ]i occurring via the NCX during low-Na + perfusion, and also to determine the effect of KBR on the Ca 2+ transients, including systolic and diastolic fluctuations during low-flow ischemia and reperfusion.
Methods

Isolated Perfused Heart Preparation
The present study was undertaken in accordance with the Animals (Scientific Procedures) Act 1986 and conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIHglucose; gassed with 100% O2, pH 7.4, maintained at 37°C) was used as the perfusate and the perfusion flow rate was maintained at 13-14 ml/min with a peristaltic pump (505S, Watson Marlow, Cornwall, UK). The pulmonary vein was cannulated for measurement of left ventricular pressure (LVP) by insertion of an 18G catheter into the left ventricle (LV) with a pressure transducer and polygraph system (SEN3101, AP641G, Nihon Kohden, Tokyo, Japan). The electrocardiogram was also monitored via carbon electrodes attached to the epicardium of the LV. Pacing leads were attached to the cannulas placed in the aorta and pulmonary vein.
Fluorescence Measurements
Cytoplasmic Ca 2+ concentrations were measured using a cell-permeable, Ca 2+ -sensitive fluorescent dye, the acetoxymethyl ester of fura-2 (fura-2; Dojindo Laboratories, Kumamoto, Japan) and an intracellular ion analyzer (CAF-110, CA-200DP; Japan Spectroscopic Co, Tokyo, Japan) as described previously. 17, 18 Briefly, the fluorescent dye was initially dissolved in dimethyl sulfoxide containing Cremophor EL (Sigma, St Louis, MO, USA; 25% w/v). The heart was loaded by re-circulating the Langendorff perfusion with Tyrode solution containing 4 mol/L fura-2 for 30 min followed by washout with standard Tyrode solution for 20 min. Excitation light of an ultraviolet (UV) frequency was transferred fiberoptically from a Xe lamp to the epicardial surface of the LV. Fluorescent light was collected through another fiber and conducted to the photomultiplier. The ratio of 500 nm fluorescence intensity excited alternately at 340 nm and 380 nm of UV light was monitored as a quantitative index of [Ca 2+ ]i. Background autofluorescence was subtracted before calculation of the ratio in the ischemia -reperfusion protocol. The autofluorescences at 340 nm and 380 nm were separately obtained from 4 unloaded hearts as an average value during aerobic, ischemic and reperfused conditions. This subtraction offset the ischemia-related alteration in the autofluorescence. To evaluate the change in diastolic [Ca 2+ ]i during ischemia and reperfusion, we used the following equation to compensate for the differences in fura-2 loading conditions in each heart: 17, 18 ∆diastolic
where R is the diastolic ratio, Rpre is the pre-ischemic diastolic ratio, and Apre is the amplitude of the pre-ischemic ratio. Each ratio was calculated from the fluorescence intensity at 340 nm divided by the intensity at 380 nm and was expressed in arbitrary units. We chose the diastolic concentration because of its minimal variation during the cardiac cycle. Calibration of fura-2 was not performed. Throughout the experiment, we simultaneously recorded fura-2 fluorescence, LVP, and heart rate. Original tracings for fura-2 fluorescence (F340, F380), ratio (F340/F380), and LVP in an untreated heart are shown in Fig 1. The tracing representing transported Ca 2+ transients (presented as the ratio) showed phasic changes, whereas the systolic and diastolic values of the fluorescence ratio remained constant.
Experimental Protocol
Series A: Low-Na + Exposure Fig 2 is the original tracings of recordings of [Ca 2+ ]i as the fura-2 fluorescence ratio, as well as LVP, in an untreated heart during control conditions and with low-Na + exposure. Fifteen hearts were perfused first with standard Tyrode solution for 10 min (control perfusion), after which the perfusate was changed to Tyrode solution containing 10 mmol/L caffeine for 5 min to induce Ca 2+ release from the sarcoplasmic reticulum (SR), depleting the Ca 2+ store. 19 To induce Ca 2+ influx via the reverse mode of NCX, 10, [20] [21] [22] hearts were then exposed to the low-Na + solution (110 mmol/L Tris aminomethane, 30 mmol/L NaCl, 6 mmol/L KCl, 1 mmol/L MgCl2, 2 mmol/L CaCl2, 10 mmol/L HEPES, 10 mmol/L glucose, 10 mmol/L caffeine, gassed with 100% O2, pH 7.4, 37°C) for 30 s. This procedure was followed by 2 min of perfusion with the Tyrode solution containing 10 mmol/L caffeine to extrude Ca 2+ from the myocytes. That sequence of perfusions was designed to specifically detect NCX-derived changes in [Ca 2+ ]i; according to a previous study using cardiac myocytes, 20, 22 low-Na + exposure alone induced not only Ca 2+ influx via the reverse mode of the NCX but also induced intracellular Ca 2+ release from the SR. 20, 22, 23 Verapamil-sensitive Ca 2+ channels were not involved in the increase in [Ca 2+ ]i resulting from low-Na + exposure, 20 so we used caffeine to exclude SR Ca 2+ release during lowNa + exposure. The effect of caffeine was reversible.
After 3 min of washout with standard Tyrode solution, the hearts were treated with 1 (n=5) or 10 mol/L KBR (n=5), and the procedure was repeated. A concentration of 30 mmol/L Na + was chosen for the low-Na + solution, as this was the lowest concentration not associated with development of ventricular fibrillation (VF). To confirm reproducibility of the results from this protocol, low-Na + exposure with pre-treatment with caffeine was performed twice in 5 additional hearts.
Series B: Ischemia -Reperfusion Protocol In the untreated group (n=6), hearts were perfused aerobically before they were exposed to low-flow ischemia for 10 min and then reperfused. Low-flow ischemia was induced by reducing the perfusion flow rate to 10% of the pre-ischemic value, while electrical pacing (140 beats/min, 0.5-1.0 V output, 2 ms pulse) was conducted. Pacing was discontinued at the end of ischemia. We had previously confirmed metabolic changes, such as an increase in lactate and a decrease in pH levels in the coronary effluent, during low-flow ischemia. 18 In the KBR-treated group (n=6), treatment with 10 mol/L KBR was initiated at 5 min prior to induction of ischemia and discontinued after 1 min of reperfusion.
Statistics
Data are expressed as the means ± SEM, sometimes after normalization relative to the baseline. Student's t-test was used to evaluate data, considering p<0.05 to indicate a statistically significant difference.
Results
Changes in [Ca 2+ ]i and LVP During Low-Na + Exposure
This report is the first to demonstrate inhibition of the reverse mode of the NCX by KBR by studying [Ca 2+ ]i dynamics in the perfused whole heart; previous experiments have only clearly demonstrated the inhibitory effect of KBR in isolated cardiac myocytes. 7, 10, 11 With normal oxygenation, pre-treatment with 10 mmol/L caffeine markedly reduced the amplitude of Ca 2+ transients and LVP, while increasing the diastolic [Ca 2+ ]i; this reflected SR Ca 2+ release and Ca 2+ depletion (Fig 2) . A small decline in [Ca 2+ ]i during the initial phase of exposure to caffeine represented Ca 2+ efflux via the forward mode of the NCX. 24, 25 In this heart model, the lower trace showing that
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LVP further decreased to zero mmHg and gradually recovered during the exposure indicated an occasional phenomenon. Subsequent low-Na + exposure induced a rapid, marked rise in [Ca 2+ ]i associated with abolition of LV developed pressure and an increase in resting pressure, which restoration of normal-Na + conditions reversed. This rise in [Ca 2+ ]i resulted mainly from Ca 2+ influx via the reverse NCX, because prior SR Ca 2+ depletion by caffeine ruled out the SR as a source. Removal of caffeine resulted in a recovery of both the amplitude of Ca 2+ transients and LVP. We then repeated the low-Na + exposure to compare the increases in diastolic [Ca 2+ ]i in untreated and KBR-treated hearts. In untreated hearts, this second low-Na + exposure provided a result similar to the first (Fig 3A) . Treatment with 1 mol/L After control perfusion with standard (normal) Tyrode's solution, the heart was pretreated with 10 mmol/L caffeine for 5 min and then exposed to low-Na + (30 mmol/L) solution for 30 s, followed by perfusion with Tyrode's solution containing caffeine and then washout of the caffeine. ]i), indicated as the fura-2 fluorescence ratio, and left ventricular pressure (LVP) during ischemia -reperfusion using a constricted scale. The heart was exposed to 10 min of low-flow ischemia followed by reperfusion. (A) Untreated heart, (B) heart treated with 10 mol/L KBR initiated 5 min prior to ischemia and discontinued after 1 min of reperfusion.
KBR before and during the second low-Na + exposure did not affect the increase in [Ca 2+ ]i (data not shown). In contrast, treatment with 10 mol/L KBR suppressed the increase in [Ca 2+ ]i during the second low-Na + exposure (Fig 3B) . In 5 untreated hearts (Fig 4, left) , the increase in [Ca 2+ ]i during the second low-Na + exposure was 84.1± 3.6% of that during the first exposure (first, 0.39±0.07 arbitrary units; second, 0.33±0.06 arbitrary units; NS). In 5 hearts treated with 10 mol/L KBR (Fig 4, right) Fig 5 shows the original tracings obtained from individual hearts throughout the ischemia -reperfusion experiment, without subtraction of background autofluorescence. In both untreated hearts and those treated with 10 mol/L KBR, diastolic [Ca 2+ ]i rose during ischemia and returned to the pre-ischemic value after reperfusion, in agreement with previous studies monitoring [Ca 2+ ]i in the low-flow ischemic rat heart using fura-2 17, 18 or indo-1. 14 The immediate increase in the diastolic ratio might be caused in part by a change in autofluorescence associated with induction of ischemia 18 because myocardial autofluorescence is known to increase during ischemia, representing increased mitochondrially derived NADH fluorescence. 14 In a previous study of myocardial autofluorescence in ischemia -reperfusion, 18 we found the ischemia-induced increase in total fluorescence to be less in the unloaded heart than in the fura-2 loaded heart. After subtraction of the autofluorescence value excited at 340 nm and 380 nm, an ischemia-associated increase in the ratio was still observed in the fura-2 loaded heart, 18 so the present increase reflected the rise in [Ca 2+ ]i in addition to the change in autofluorescence. During ischemia, the diastolic [Ca 2+ ]i in the untreated heart increased to exceed the pre-ischemic systolic [Ca 2+ ]i (Fig 5A) , although this change in [Ca 2+ ]i was attenuated in hearts treated with 10 mol/L KBR (Fig 5B) , in agreement with previous experiments using cardiac myocytes. 7 LVP rapidly decreased after induction of ischemia, but partially recovered after reperfusion. In the untreated heart (Fig 5A) , LVP transiently recovered and gradually decreased during ischemia. This phenomenon was occasionally observed with and without treatment. Only at 1 min of ischemia, LVP was greater in untreated hearts than in KBR-treated hearts (Table 1 ) but no significant difference was observed between the 2 groups in the %LVP at baseline (46.1±8.4% vs 30.7±3.4%). The amplitude of Ca 2+ transients decreased slightly during ischemia and partially recovered after reperfusion (Fig 5) . Similar results were obtained from our previous studies using perfused hearts and isolated cells. 18, 25 The decrease in amplitude of Ca 2+ transients might be explained mainly by reduction of Ca 2+ release from the SR or depletion of Ca 2+ stores in the SR. No significant difference in the amplitude of transients was noted between the 2 groups. Pre-ischemic, end-ischemic and reperfused values of the amplitude were 0.16±0.02, 0.12±0.02, 0.13±0.01 (arbitrary units) in untreated hearts and 0.17±0.01, 0.13± 0.01, 0.15±0.01 in KBR-treated hearts.
Changes in [Ca 2+ ]i and LVP During Ischemia and Reperfusion
Changes in Diastolic [Ca 2+ ]i During Ischemia and Reperfusion
Before subtraction of autofluorescence, pre-ischemic diastolic [Ca 2+ ]i was similar (fluorescence ratio; 0.79±0.03 vs 0.80±0.01, NS) in untreated and KBR-treated hearts. Fig 6 shows (Fig 7) . Pre-ischemic diastolic [Ca 2+ ]i was also similar (fluorescence ratio; 0.66±0.05 vs 0.67±0.01, NS) in untreated and KBR-treated hearts. In the untreated Fig 6 . Averaged changes in diastolic intracellular Ca 2+ ([Ca 2+ ]i), indicated as the fura-2 fluorescence ratio, in hearts exposed to 10 min of low-flow ischemia followed by reperfusion. The period of ischemia is shown as a frame. *p<0.05, **p<0.01 vs untreated hearts. ]i), indicated as the fura-2 fluorescence ratio, in hearts exposed to 10 min of low-flow ischemia followed by reperfusion. Background autofluorescence was subtracted. The period of ischemia is shown as a frame. *p<0.05 vs untreated hearts. 
Changes in Hemodynamics
Hemodynamic parameters during the pre-ischemic, ischemic and reperfusion conditions are summarized in Table 1 . Treatment with 10 mol/L KBR did not influence heart rate or LVP in the pre-ischemic state. Although the reverse mode of the NCX has been shown to contribute to contraction, 11 blockade of the NCX did not affect the hemodynamics in nonischemic hearts. Treatment of guinea-pig papillary muscle with 10 mol/L KBR did not significantly affect the action potential parameters. 10 After reperfusion, the LVP tended to be greater in KBRtreated hearts than in untreated hearts (LVP at 1 min of reperfusion: see Table 1 , p=0.18; %LVP of baseline at 1 min: 84.5±7.2 vs 64.3±15.8, p=0.22). Moreover, KBR accelerated recovery of the rate -pressure product (Fig 8) .
Discussion
We investigated the effects of KBR, a selective inhibitor of the reverse mode of the NCX, on Ca 2+ transients and LVP during low-Na + exposure and ischemia -reperfusion in the beating intact heart. Treatment with KBR suppressed the increase in [Ca 2+ ]i resulting from Ca 2+ influx via reverse mode NCX induced by low-Na + exposure, and also reduced the ischemia-induced rise in diastolic [Ca 2+ ]i. After reperfusion, KBR improved cardiac function in terms of the rate -pressure product.
Effect of KBR on the NCX
Although KBR predominantly inhibits the reverse mode of the NCX in isolated myocytes, 7,10,11 only a few studies have addressed the intracellular ionic dynamics of the isolated perfused heart because of the difficulties in assessing ion transporter function. Baartscheer et al estimated that the relative contribution of Ca 2+ influx via reverse mode NCX to the increase in [Ca 2+ ]i induced by zero-Na + exposure in isolated rat ventricular cardiac myocytes was approximately 45% of the total increase in [Ca 2+ ]i, and ryanodine-sensitive Ca 2+ release from SR similarly accounted for approximately 45%; Ca 2+ influx via verapamil-sensitive Ca 2+ channels was negligible. 20 In addition, reduction of extracellular Na + from 156 to 29 mmol/L sufficiently reversed the driving force, the free energy of NCX in myocytes pretreated with ryanodine. 22 If SR function is inhibited, the functional activity of the reverse mode of NCX can be evaluated essentially in isolation by observing the increase in [Ca 2+ ]i. The caffeine-induced slight increase in diastolic [Ca 2+ ]i is unlikely to offset the reversal of the NCX. Caffeine also has a phosphodiesterase (PDE) inhibitory action and may increase cAMP levels. These effects could be related to positive inotropism and arrhythmogenesis. However, the use of caffeine is well-established as a tool for assessing cellular Ca 2+ handling 19, 24, 25, 30 and a high concentration of caffeine depletes the SR Ca 2+ . Thus, these additional effects of caffeine would have had a minimal influence on the current results.
In isolated myocytes, treatment with KBR inhibited the increase in [Ca 2+ ]i induced by exposure to a zero-Na + solution in a concentration-dependent manner, with complete abolition at 10 mol/L. 10 However, reduction of the [Ca 2+ ]i increase by 10 mol/L KBR was only approximately 60% in this study. The lesser effectiveness of KBR on the NCX in the intact heart might be explained by differences in the extracellular environment: isolated myocytes may be more directly exposed to the drugs. Another explanation for discrepancy is the difference in workload or metabolic consequences.
Effects of the NCX Inhibitor on [Ca 2+ ]i During Ischemia and Reperfusion
Several investigations using whole-heart preparations, [12] [13] [14] 17, 18 as well as isolated cell models, [6] [7] [8] 25 have demonstrated alterations in Ca 2+ -dependent fluorescence transients during ischemia and reperfusion. No-flow ischemia arrested the heart beat, resulting in abolition of Ca 2+ transients. In the present study we used a model of low-flow ischemia in which we could evaluate pharmacologic inhibition of Ca 2+ overload during ischemia in the beating heart. A similar slight decrease in the amplitude of the Ca 2+ transient associated with a decrease in LVP occurred during ischemia in both untreated and KBRtreated hearts. Assessment of intracellular Ca 2+ kinetics using rapid caffeine application indicated that reduction of SR Ca 2+ stores occurs during anoxia, 25 and an ischemiainduced reduction of SR Ca 2+ uptake was demonstrated using a biochemical assay. 26 It is unlikely that KBR modified SR dysfunction during ischemia.
In an investigation of the correlation between diastolic [Ca 2+ ]i and ventricular contractility after reperfusion, hearts exposed to ischemia for a longer period (30 min) exhibited significantly slower contractile recovery (LVP) and higher diastolic [Ca 2+ ]i in early reperfusion than hearts subjected to a shorter period of ischemia (10 min). 18 Therefore, elevation of diastolic [Ca 2+ ]i might be an important determinant of contractile dysfunction in ischemia-reperfusion. Another study also showed a significant role of the degree of the end-ischemic Ca 2+ overload in reoxygenation-induced myocyte hypercontracture. 27 In the present study, treatment with KBR significantly suppressed the ischemic increase in diastolic [Ca 2+ ]i and accelerated the reperfusion-induced decline of diastolic [Ca 2+ ]i, which is consistent with results obtained in isolated cells, 7 again suggesting that the cardioprotective effect of KBR results in part from reduction of [Ca 2+ ]i overload by inhibiting the reverse mode of the NCX.
Our finding of the ischemic increase in diastolic [Ca 2+ ]i was consistent with reported results in intact hearts. [12] [13] [14] 17, 18 Nuclear magnetic resonance detected an increase in [Ca 2+ ]i after 15-20 min of ischemia, 28 so the time to the onset of increase in [Ca 2+ ]i might depend on the method of investigation. In our previous studies, 21, 25 hypoxia caused inhibition of the exchanger in a few minutes. Therefore, the rise in diastolic [Ca 2+ ]i during the early phase of ischemia might result partly from functional suppression of the forward mode of the NCX. Inhibition of the NCX may be explained by a decrease in intracellular pH, 29, 30 extracellular pH 31 and/or ATP. 32 We have demonstrated intracellular acidosis in intact hearts during global ischemia using a fluorescent intracellular pH indicator. 33 Taking these findings into consideration, how did KBR, 7 and this effect might inhibit functional activity of the reverse mode of the NCX.
Despite earlier suggestions that myocardial Ca 2+ content might increase during reperfusion, 34 most studies using fluorescent dye, such as in the present study, have shown a decline in diastolic [Ca 2+ ]i during reperfusion following ischemia. [12] [13] [14] In a less injured (reversible damaged) heart exposed to brief ischemia, removal of cytoplasmic Ca 2+ by SR might overcome the influx of Ca 2+ via the reverse mode of the NCX after reperfusion. The contribution of the SR to Ca 2+ extrusion is greater in the rat heart than in rabbit or guinea-pig hearts. 35 Recovery of the amplitude of Ca 2+ transients was also mainly mediated by restoration of SR Ca 2+ uptake and Ca 2+ stores. 25, 26 In the present study, untreated hearts still exhibited a higher diastolic [Ca 2+ ]i early reperfusion. More rapid decline (normalization) of diastolic [Ca 2+ ]i in the KBR-treated heart might also be a consequence of the inhibitory effect of this agent on the NCX. Hearts from mice overexpressing the NCX may be more susceptible to ischemia -reperfusion injury. 36 On the other hand, artificially enhanced gene expression for the NCX has been found to preserve Ca 2+ homeostasis during ischemia and hypoxia in failing mouse hearts. 37 The role of the NCX in abnormal Ca 2+ handling during the late phase of ischemia and in reperfusion remains a matter of debate.
Study Limitations
It has been reported that KBR is not a purely selective inhibitor of NCX. In guinea-pig ventricular myocytes, the IC50 was 0.32 mol/L for inhibition of the reverse mode of the NCX, but was 17 mol/L for the forward mode. KBR also inhibited the voltage-gated Na + current, Ca 2+ current and the inward K + current, but with a higher IC50s of 14, 8 and 7 mol/L, respectively. 38 Although we could not completely exclude the effect of KBR on these ion transporters, a previous study reported that 10 mol/L KBR did not affect the Na + /H + exchanger, Ca 2+ channel, SR Ca 2+ -ATPase or Na + /K + -ATPase in rat smooth muscle cells and cardiac myocytes. 10 We should consider certain problems arising from using a fluorescent dye to measure [Ca 2+ ]i in the isolated perfused heart. Changes involving a fraction of fura-2 fluorescence derived from nonmyocyte sources, particularly endothelial cells, have been suggested, 14, 15, 18, 39 although the fraction derived from endothelial cells is unlikely to change remarkably during the cardiac cycle. Thus, meaningful differences in [Ca 2+ ]i dynamics could be found between the untreated heart and the KBR-treated heart. Miyata et al showed that the intensity of indo-1 fluorescence in mitochondria also changed during anoxia, whereas the characteristics of Ca 2+ transients were stable in normoxic myocytes. 40 Assessment of ischemic change in mitochondrial fura-2 fluorescence remains to be established in the whole-heart model. We observed fura-2 fluorescence mainly from the epicardium. A previous study evaluated the relationship between indo-1 fluoresence intensity and distance from the sampling probe in the isolated rabbit heart and found that 90% of fluorescence arises from within 850 m of the surface (ie, subepicardium). Although the fluorescence seems to vary synchronously with contraction, the change in [Ca 2+ ]i was in part concealed in the mid-and endomyocardium. 41 We did not calibrate fura-2 fluorescence, which will be necessary for comparison of [Ca 2+ ]i in the intact heart with that in models representing diseased hearts. Despite these problems, the characteristics of fura-2 fluorescence (Ca 2+ transients) obtained from isolated perfused rat hearts were appropriate for assessment of intracellular Ca 2+ handling. The advantages of fluorescence indicators include the ability to monitor real-time changes in [Ca 2+ ]i and LVP simultaneously, and to assess the pharmacologic effect on [Ca 2+ ]i dynamics during ischemia -reperfusion in the intact heart.
In conclusion, inhibition of the reverse mode of the NCX by KBR, a selective inhibitor, resulted in reduction of intracellular Ca 2+ overload and acceleration of recovery of myocardial contractility during ischemia and reperfusion in the intact heart model.
